Search Results

An ecosystem where GPCR innovation accelerated — not because of a single star scientist, but because aren’t just built on brilliance November 14, 2025 Dr.GPCR Podcast Read full article Scientific careers In this conversation, Michelle Halls reminds us of something every scientist eventually learns: hard In this clip, Jens unpacks a mindset shift that every computational scientist should hear. Terry’s Corner was built to make advanced pharmacology practical: a space where scientists don’t just

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

Young scientists are hungry for alternate career paths. is the heart of scientific innovation Who Should Listen PhD students and postdocs exploring biotech careers GPCR scientists interested in translational innovation Biotech investors and strategic leaders seeking Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined Leave a quick review to help more scientists find the show—and help us keep improving every episode.

I then pressed record, and we chatted for almost 2h about Bob’s career, discoveries, difficulties (yes He began his career in the late 1960s and has been an Investigator of the Howard Hughes Medical Institute careers. web A Funny Thing Happened on the Way to Stockholm: The Adrenaline-Fueled Adventures of an Accidental Scientist Leave a quick review to help more scientists find the show—and help us keep improving every episode.

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially as a synthesis of the different knowledge, experiences, and know-how from the different stages of my career Leave a quick review to help more scientists find the show—and help us keep improving every episode.

At this point in my career, I am creating connections with biomedical industry, assessing professional opportunities, and seriously weighing strengths of career options across sectors; however, academia I want to connect more trainees with diverse career resources to support professional decision-making endeavors, will inform my future career decisions." Leave a quick review to help more scientists find the show—and help us keep improving every episode.

From early discoveries in cyclic AMP signaling to uncovering ultrasensitive receptor responses at femtomolar This conversation is especially valuable for scientists developing functional assays, fluorescence-based What early cyclic AMP assays revealed about spatial signaling long before high-content technologies existed Join a global GPCR community of scientists and biotech leaders. 👉 Join now Enjoying the Dr. Leave a quick review to help more scientists find the show—and help us keep improving every episode.

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

. 👉 It has become an early signal of whether a biotech company is fundable at all. , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally Internal meetings slowly morph into scientific colloquia instead of decision-making forums. 👉 The uncomfortable

preserving original work, the value of international conferences, and the dynamics between junior and senior scientists Ferns', the importance of maintaining team culture, and the potential health issues among well-known scientists The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance Lastly, they deliberated on involving junior scientists and postdocs in their podcast and the possibility Leave a quick review to help more scientists find the show—and help us keep improving every episode.